86
Participants
Start Date
June 1, 2023
Primary Completion Date
June 4, 2025
Study Completion Date
December 31, 2025
barzolvolimab
subcutaneous administration
Matching Placebo
subcutaneous administration
NYU Langone Health, New York
The Pennsylvania State University (Penn State) Milton S. Hershey Medical Center, Hershey
University of Pennsylvania, Philadelphia
University of North Carolina (UNC) Hospitals, Chapel Hill
Duke University Medical Center, Durham
ENCORE Borland Groover Clinical Research, Jacksonville
Gastroenterology of Greater Orlando, Orange City
AllerVie Clinical Research, Birmingham
Vanderbilt University Medical Center-GI Clinical Research Program, Nashville
The Clinical Trials Network, LLC, Willoughby
University of Iowa, Iowa City
Northwestern University, Chicago
University of Kansas Medical Center (KUMC), Kansas City
Tandem Clinical Research, Marrero
Treasure Valley Medical Research, Boise
Care Access Research, Salt Lake City
University of Utah, Salt Lake City
Advanced Research Institute - Ogden, Ogden
One of a Kind Clinical Research Center, Scottsdale
GI Alliance- Arizona Digestive Health- Sun City, Sun City
Del Sol Research Management, LLC, Tucson
GW Research Inc., Chula Vista
Connecticut Clinical Research Institute, LLC, Bristol
Boston Specialists - Boston Food Allergy Center, Boston
Royal Adelaide Hospital, Adelaide
The Alfred Hospital, Melbourne
St Vincent's Hospital Melbourne, Melbourne
University of Calgary, Calgary
PerCuro Clinical Research Ltd., Victoria
Universitaetsklinikum Augsburg, Augsburg
Klinikum Region Hannover GmbH Burgwedel, Hanover
Universitaetsklinikum Magdeburg A.oe.R., Magdeburg
IRCCS Ospedale San Raffaele, Milan
Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Rome
Istituto Clinico Humanitas, Rozzano
"Azienda Ospedaliera Universitaria OO.RR. San Giovanni di Dio Ruggi d'Aragona-Plesso Ruggi", Salerno
Azienda Ospedaliera - Universitaria Integrata di Verona - Ospedale Borgo Roma, Verona
Centrum Medyczne Med-Gastr Sp. z o.o., Lodz
WIP Warsaw IBD Point Profesor Kierkus, Warsaw
Wojskowy Instytut Medyczny - Panstwowy Instytut Badawczy, Klinika Gastroenterologii i Chorob, Warsaw
Hospital General Universitario de Alicante Dr. Balmis, Alicante
Hospital Clinico San Carlos, Madrid
St George's Hospital, London
St. Thomas' Hospital, London
Norfolk and Norwich University Hospital, Norwich
Lead Sponsor
Celldex Therapeutics
INDUSTRY